Elevating Québec’s Research and Innovation Capabilities Through International Collaboration Québec, known for its rich cultural heritage and stunning landscapes, is also making waves in the realms of research, development, and innovation. One key driving force behind the province’s advancements in these areas is international collaboration. Marco Blouin, a prominent figure in Québec’s innovation ecosystem, sheds […]
Aqemia's Global Expansion Fueled by New Investments
Aqemia, a Paris-based biotechnology company, is making headlines with its ambitious plans for global expansion following a recent funding round. The company’s innovative approach seeks to revolutionize drug development using artificial intelligence, which has the potential to reshape the landscape of cancer and immuno-oncology research. Founded with the vision of accelerating drug discovery processes, Aqemia […]
AI Tool Revolutionizes Lung Cancer Detection
In a significant advancement for medical technology, healthcare professionals have begun implementing an AI-powered tool designed specifically for the early detection of lung cancer. This innovative system has already shown promising results, marking a pivotal shift in the way cancers can be diagnosed and treated effectively, ultimately improving patient outcomes. The AI application focuses on […]
Orakl Oncology: Transforming Cancer Drug Development
In a landscape where traditional cancer treatment methods often fall short, innovative approaches are essential. One promising startup, Orakl Oncology, is setting the stage for a revolutionary change in cancer drug development by harnessing the power of artificial intelligence and organoid-based testing. Located in France, this company aims to enhance the efficiency of clinical trials […]
AI to Simulate Cancer Trials with £5.9 Million Funding
The landscape of cancer research is on the brink of transformation, thanks to a groundbreaking project initiated by researchers at the University of Manchester and The Christie Cancer Hospital. With a substantial grant of £5.9 million from Cancer Research UK, the team is set to leverage artificial intelligence (AI) to simulate clinical trials. This innovative […]
Rianta Capital Invests In Biotech Beauty Brand
In an era where innovation shapes the beauty landscape, the UK-based biotech skincare brand, Reome, has captured attention with its successful first round of funding. Launched by former beauty editor Joanna Ellner in January 2023, Reome recently raised over £1.1 million ($1.4 million) led by Rianta Capital, the investment arm of New Look founder Tom […]
AstraZeneca Invests $18 Million in Immunai's AI Technology
In a significant move highlighting the growing intersection of artificial intelligence and biopharmaceuticals, AstraZeneca has committed $18 million to Immunai Inc., a pioneer in AI-driven immunology research. This investment marks a strategic effort by AstraZeneca to enhance the precision and efficiency of its cancer drug trials, leveraging cutting-edge technology to navigate the complexities of immune […]